Brief: BBS-Bioactive Bone Substitutes H1 Net Loss Narrows To EUR 0.8 Million

BBS-Bioactive Bone Substitutes Oyj

30/08/2019 07:12

Aug 30 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
 BONEH.HE :
    * FOR YEAR 2019, SUBSTANTIAL NET SALES ARE NOT EXPECTED TO
BE
GENERATED
    * CE MARKING WILL NOT TO BE OBTAINED DURING 2019
    * COMPANY HAD NO NET SALES DURING PERIOD UNDER REVIEW
    * H1 LOSS EUR 0.8 MILLION VERSUS LOSS EUR 1.1 MILLION YEAR
AGO
    * OUTLOOK FOR 2020 BBS WILL PERFORM ADDITIONAL ANIMAL
STUDIES AND
DRIVE FORWARD CE MARKING PROCESS OF FIRST PRODUCT AND LAUNCH
SALES AND MARKETING PREPARATIONS.

Source text for Eikon:  ID:nGNEc39kdh 
Further company coverage:  BONEH.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))